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• Appear uptakes with a size=1 voxel 
• Minimum hypoxic volume to consider in cubic centimeters. 
• Part of the FMISO uptake is outside FDG uptake. 
• We can't visualize 3 series of fused images at once (FDG CT 
– FDG PET – FMISO PET). 
• Placing the patient in the PET-CT unit has to make it 
radiotherapy technician so that involves travel to other 
centers on the PET-CT days. 
• We can't use devices to immobilize the patient because the 
diameter of the PET-CT unit is smaller than Radiotherapy CT. 
Conclusions: 
1. Imaging fusion by existing treatment planning stations is 
simple and does not require excessive time, but specific 
training for radiotherapy technicians is necessary. 
2. 18F-FMISO PET is only authorized within the clinical trials, 
so having few cases, both learning and solving doubts is a 
slow process. 
3. Making a CT in our service can provide a better position by 
using immobilization devices by an expert radiotherapy 
technician, but that would cause more radiation to the 
patient. 
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Purpose/Objective: To assess if DIBH achieved dose sparing 
for organs-at-risk in left breast radiotherapy. These patients 
have an increased risk of cardiac complications post-
treatment compared to right breast patients. Deep 
inspiration breath-hold (DIBH) could potentially reduce dose 
to organs-at-risk without compromising target dose, thus 
potentially reducing complication incidence and improving 
overall patient survival. 
Materials and Methods: Free breathing (FB) and DIBH CT 
planning scans obtained using Varian RPM Gating software for 
28 left breast/left chest wall (plus/minus supraclavicular 
field) patients treated between January 2008-December 2013 
were retrospectively re-contoured and re-planned. Organs-
at-risk included the combined lungs, left lung, heart and left 
anterior descending coronary artery (LADCA). Field-in-field 
tangential technique (mono-isocentric for supraclavicular 
patients) and Anisotropic Analytical Algorithm (AAA) were 
used for dose calculations. Maximum plan doses were kept 
within 1% agreement between FB and DIBH plans for 
comparative purposes. Quantitative analysis of plan dose 
differences was then carried out. 
Results: Lung dose was not affected by DIBH. Heart Dmax was 
reduced by 34.5% (FB=41.81Gy, SD=3.963Gy vs DIBH=27.39Gy, 
SD=12.393Gy, p<0.000). Heart Dmean was reduced by 32.6% 
(FB=1.817Gy, SD=0.627Gy vs DIBH=1.224Gy, SD=0.344Gy, 
p<0.000). DIBH removed heart in 28.6% (n=8) of participants’ 
treatment fields. LADCA Dmax was reduced by 47.8% (DIBH 
mean=15.56Gy, SD=10.62Gy vs. FB mean=29.82Gy, 
SD=10.05Gy, p<0.000), and LADCA Dmean by 52% (DIBH 
mean=5.23Gy, SD=1.94Gy vs. FB mean=10.88Gy, SD=3.95Gy 
p<0.000). Amplitude depths were not correlated with dose 
reductions. 
Conclusions: DIBH results in heart and LADCA dose 
reductions, without increasing lung dose. Further long-term 
follow-up is required to evaluate the clinical implications for 
patients.  
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Purpose/Objective: To compare the dosimetric difference of 
volumetric modulated arc therapy(VMAT) and fixed-jaw 
technique in volumetric modulated arc therapy(FJT-VMAT) 
for nasopharyngeal carcinoma(NPC). 
Materials and Methods: VMAT and FJT-VMAT plans were 
designed to 15 nasopharyngeal carcinoma patients by 
planning treatment system(Eclipse 10.0),respectively. The 
target and risk organ doses, conformity indexes (CI), 
homogeneity indexes (HI), low dose volume of normal tissue, 
monitor units(MU) and treatment time (TT) were compared 
between the two kinds of plans. 
Results: Two Plans could meet the clinical objectives. The 
Dmean, D50, D2 of PGTVnd, PTV1, PTV2 were lower in FJT-VMAT 
plans than in VMAT plans (P<0.05). There were no significant 
different in PGTVnx between them. FJT-VMAT plans had 
lower PRVBstem(Dmax, V54), PRVsc(Dmax), Parotid(Dmean, V30) and 
B-P( V20, V30)(P<0.05), but no significantly different with 
other OARs as compared with VMAT plans. FJT-VMAT 
plans(683±87)increased the monitor units(MU) by 22%(t =-
5.78, P =0.000), as compared with VMAT plans(559±62). The 
treatment time of two plans were consistent (about 2 min).  
Conclusions: FJT-VMAT plans as compared with VMAT plans, 
showing better target coverage, part of OARS and B-P 
sparing, which MU was slightly increased but not significantly 
different between the two plans of treatment time. 
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Purpose/Objective: To achieve homogeneous dose 
distribution in the intensity-modulated radiotherapy (IMRT) 
for Stage III lung cancer is challenging. A novel method 
utilizing base dose function (BDF) was proposed to overcome 
the difficulty and was evaluated in this study. 
Materials and Methods: CT scan data of 13 patients were 
enrolled. Three optimizing approaches were applied to obtain 
clinically acceptable plans: 1) Conventional optimizing (CO) 
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method; 2) Target-divided optimizing (TDO) method in which 
the optimization objective was set to 2-4 Gy higher for the 
planning target volume (PTV) within lung; 3) Base-dose-
function (BDF) method: with optimization objectives being 
unmodified, the treatment plan copied from the original plan 
with half of total fractions was re-optimized based on the 
original plan with half of total fractions, and then the 
number of fractions of treatment plan was restored from a 
half to the total one. CO, TDO and BDF methods were then 
compared in PTV homogeneity index (HI), conformity index 
(CI), organs at risk (OARs) sparing and monitor units (MUs). 
Additionally, three verification tools, Delta4, Portal 
Dosimetry and IMSure were employed to measure the dose 
delivery accuracy. 
Results: BDF method provided superior HI over TDO and CO 
methods by about 38% and 54% respectively, and provided 
superior CI over TDO and CO methods by about 3% and 7% 
respectively. Considering the OARs sparing, BDF method 
reduced the dose delivered to the lung, spinal cord, 
esophagus and heart by about 0.2-3.8Gy. However, the BDF 
plans needed about 9-15% more monitor units (MUs) than the 
other two methods. All the verification results had good and 
comparable γ pass rates among the 3 methods.  
 
 
 
Conclusions: The proposed BDF method can achieve 
excellent homogeneous dose distribution, and it can also 
improve the target conformity as well as the OARs sparing, in 
the IMRT for Stage III lung cancer. 
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Purpose/Objective: A Generic Template with no specific 
adjustments for tumour type is used at our hospital for linear 
accelerator-based radiosurgery treatment planning. It 
involves further manual adjustments of the micro-multileaf 
collimator (mMLC) leaves in all the generic arcs for improving 
the treatment plan quality which is a cumbersome task. The 
purpose of this work is to present specific templates for right 
and left acoustic neurinomas and compare their performance 
with the Generic Template in terms of plan quality, and to 
determine the minimum number of arcs where the mMLC 
shape must be adjusted for the treatment plan to comply 
with the local acceptability criteria. 
Materials and Methods: The treatment plans of 12 cases of 
already treated right acoustic neurinomas were analysed. 
From this retrospective study, a Specific Template for right 
acoustic neurinoma was created and the Specific Template 
for left acoustic neurinoma was defined as precisely the 
mirror of the right template. In total, 19 cases involving 
acoustic neurinomas have been re-planed with the Specific 
Template (right or left) and their plan quality assessed. 
Treatment planning was conducted using the iPlan RT Dose 
planning system, version 4.5 from BrainLAB. The target 
volumes ranged from 0.265-7.523 cc (mean: 2.085 ± 1,772 cc) 
and the prescribed dose was 12-14 Gy (mean: 12.15 ± 0.50 
Gy). Treatment plans were generated using 6 dynamic 
conformal arcs and their quality evaluation was assessed 
through the calculation of dose-volume indices and dose 
distribution analysis. 
Results: The Specific Template performed better than the 
Generic Template in terms of conformity (COIN = 0.558 ± 
0.034 for the Specific Template and COIN = 0.547 ± 0.034 for 
the Generic Template) and critical organ sparing (COIN’= 
0.554 ± 0.031 for the Specific Template and COIN’ = 0.538 ± 
0.031 for the Generic Template). The coverage and the 
homogeneity of the dose distribution were similar for both: 
TC = 0.981 ± 0.007, MDPD = 1.065 ± 0.013 for the Specific 
Template and TC = 0.984 ± 0,007, MDPD = 1.067 ± 0.013 for 
the Generic Template. 
Conclusions: Applying the proposed Specific Template for 
acoustic neurinoma, the compliance to local acceptance 
quality criteria was achieved with manual correction of the 
mMLC leaves for just two of the six dynamic arcs used for 
treatment. This represented a considerable reduction – to 
around 1/3 - of the treatment planning time, accomplishing 
the purpose of the present work which was speeding up the 
treatment planning phase in radiosurgery without 
jeopardizing the plan quality. 
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Purpose/Objective: Esophageal toxicity is a common acute 
side-effect of external radiotherapy for chest tumors. There 
is no clear relation with different etiologies as esophageal 
doses, length of irradiated organ, volumes, etc. Dose-volume 
histogram (DVH) shows several parameters that can help us 
to understand this toxicity 
Our objective was to analyze esophageal toxicity at the end 
of radiotherapy treatment and relate it with the DVH 
parameters mean dose (Dmean) and maximum dose (Dmax)  
